Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...

Current use of hydroxychloroquine is associated with a lower risk for myocardial infarction (MI), stroke, and other thromboembolic events in patients with systemic lupus erythematosus (SLE). This ...

Antimalaria drugs that U.S. President Donald Trump has touted for treatment of Covid-19 were linked to an increased risk of death and heart ailments in a study. Hydroxychloroquine and chloroquine didn ...

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

Use of hydroxychloroquine during pregnancy in patients with systemic lupus erythematosus (SLE) is associated with a reduced risk for preeclampsia, according to a recent nationwide cohort study. A ...

Hydroxychloroquine use may lower the risk for new-onset diabetes among patients with primary Sjögren syndrome. Hydroxychloroquine (HCQ) use significantly lowers the risk for new-onset diabetes among ...

Add Yahoo as a preferred source to see more of our stories on Google. Rep. Austin Baeth, D-Des Moines, an internal medicine physician, spoke in opposition to a bill on establishing over-the-counter ...

Add Yahoo as a preferred source to see more of our stories on Google. A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally ...